Figure 5

ACAN levels in ATAAD patients are not influenced by basic demographic parameters or the course of ATAAD. (a) ACAN levels in female (n = 15) and male (n = 18) ATAAD patients. (b) ACAN levels in ATAAD patients of different age (40–49 y, n = 3; 50–59 y, n = 6; 60–69 y, n = 12; 70–79 y, n = 9; ≥ 80 y, n = 3). (c) ACAN levels in DeBakey type I (n = 18) or type II (n = 15). (d) Correlation of ACAN levels and site of intimal tear. MAA (n = 11), AR (n = 10). (e) ACAN levels at 6 (n = 8), 12 (n = 8), 24 (n = 6), 48 (n = 3) or 72 h (n = 2) after the onset of the disease. MAA mid-ascending aorta, AR aortic root. Values are presented as means ± SEM. Significance of difference was tested with Wilcoxon-Mann–Whitney test or one-way ANOVA test.